Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells

Blood

Volumn 100, Issue 8, 2002, Pages 2753-2762

  Rane, Sushil G ^a   Mangan, James K ^a   Amanullah, Arshad ^a   Wong, Brian C ^a   Vora, Renu K ^a   Liebermann, Dan A ^a   Hoffman, Barbara ^a   Graña, Xavier ^a   Premkumar Reddy, E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; CYCLOHEXIMIDE; DACTINOMYCIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; JANUS KINASE; PROTEIN P27; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GRANULOCYTE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; WESTERN BLOTTING;

EID: 0037108112     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.8.2753     Document Type: Article

References (46)

1. Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene. 2000;19:5662-5679.
2. Rane SG, Reddy EP. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene. 1994;9:2415-2423.
3. Gaozza E, Baker SJ, Vora R, Reddy EP. AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells. Oncogene. 1997;15:3127-3135.
4. Kirken RA, Rui H, Malabarba MG, Farrar WL. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem. 1994;269:19136-19141.
5. Johnston JA, Kawamura M, Kirken RA, et al. Phosphorylation and activation of the JAK-3 Janus kinase in response to interleukin-2. Nature. 1994;370:151-153.
6. Miyazaki T, Kawahara A, Fujii H, et al. Functional activation of JAK1 and JAK3 by selective association with IL-2 receptor subunits. Science. 1994;266:1045-1047.
7. Witthuhn BA, Silvennoinen O, Miura O, et al. Involvement of the JAK-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 1994;370:153-157.
8. Takahashi T, Shirasawa T. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. FEBS Lett. 1994;342:124-128.
9. Zeng YX, Takahashi H, Shibata M, Hirokawa K. JAK3 Janus kinase is involved in interleukin 7 signal pathway. FEBS Lett. 1994;353:289-293.
10. Park SY, Saijo K, Takahashi T, et al. Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. Immunity. 1995;3:771-782.
11. Thomis DC, Gumiak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking JAK3. Science. 1995;270:794-797.
12. Nosaka T, van Deursen JM, Tripp RA, et al. Defective lymphoid development in mice lacking JAK3. Science. 1995;270:800-802.
13. Grossman WJ, Verbsky JW, Yang L, et al. Dysregulated myelopoiesis in mice lacking JAK3. Blood. 1999;94:932-939.
14. Patel G, Kreider B, Rovera G, Reddy EP. v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation. Mol Cell Biol. 1993;13:2269-2276.
15. Rovera G, Valtieri M, Mavilio F, Reddy EP. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene. 1987;1:29-35.
16. Valtieri M, Tweardy D, Caracciolo D, et al. Cytokine-dependent granulocytic differentiation: regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol. 1987;138:3829-3835.
17. Nicholson SE, Oates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton J. Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci U S A. 1994;91:2985-2988.
18. Shimoda K, Iwasaki H, Okamura S, et al. G-CSF induces tyrosine phosphorylation of the JAK2 protein in the human myeloid G-CSF responsive and proliferative cells, but not in mature neutrophils. Biochem Biophys Res Commun. 1994;203:922-928.
19. Tian SS, Lamb P, Seidel H, Stein RB, Rosen J. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood. 1994;84:1760-1764.
20. McMahon SB, Monroe JG. Role of primary response genes in generating cellular responses to growth factors. FASEB J. 1992;6:2707-2715.
21. Steinman RA, Tweardy DJ. Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood. 1994;83:119-127.
22. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281-319.
23. Lamer AC, Finbloom DS. Protein tyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes. Biochem Biophys Acta. 1995;41:278-287.
24. Kawahara A, Minami Y, Miyazaki T, Ihle JN, Taniguchi T. Critical role of the interleukin 2 (IL-2) receptor g -chain-associated JAK3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci U S A. 1995;92:8724-8728.
25. Mayol X, Garriga J, Graña X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene. 1995;11:801-808.
26. Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene. 2000;19:2532-2547.
27. Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995;11: 211-219.
28. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000;60:3689-3695.
29. Halevy O, Novitch BG, Spicer DB, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995;267:1018-1021.
30. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB. Induction of differentiation human promyelocytic HL-60 leukemia cells activates p21WAF1/CIP1, expression in the absence of p53. Oncogene. 1994;9:3397-3406.
31. Parker SB, Eichele G, Zhang P, et al. p53-independent expression of p21/CIP1 in muscle and other terminally differentiating cells. Science. 1995;267:1024-1027.
32. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann D, El-Houseini M. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 1994;9:3389-3396.
33. Liu M, Lee M, Cohen M, Bommakanti M, Freedman M. Transcriptional activation of the CDK inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996;10:142-153.
34. Kranenburg O, Schamhorst V, Van der Eb A, Zantema A. Inhibition of cyclin dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol. 1995;131:227-234.
35. Kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995;9:639-649.
36. Cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995;9:650-662.
37. Polyak K, Kato J, Solomon M, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factorbeta and contact inhibition to cell cycle arrest. Genes Dev. 1994;8:9-22.
38. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol. 1994;14:3683-3694.
39. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 1995;9:1831-1845.
40. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow: RB6-8C5 mAb to granulocyte differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993;151:2399-2408.
41. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331-334.
42. Wang X, Scott E, Sawyers CS, Friedman AD. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU. 1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood. 1999;94:560-571.
43. McLemore M, Grewal S, Liu F, et al. STAT3 activation is required for normal G-CSF dependent proliferation and granulocytic differentiation. Immunity. 2001;14:193-204.
44. Kip1. Oncogene. 2000;19:3290-3298.
45. Rodig SJ, Meraz MA, White JM, et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 1998;93:373-383.
46. Parganas E, Wang D, Stravopodis D, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998;93:385-395.